Medication, Nutrient Depletion and Mental Wellness
Presented by Dr. Krista Anderson Ross, ND | May 6, 2026 at 12 PM Pacific
Learning Objectives:
- Mechanisms by which commonly used medications contribute to nutrient depletions that impact neurotransmitter synthesis and mitochondrial function.
- Identify the key nutrients essential for mental health-including B-vitamins, magnesium, zinc, and CoQ10-and explain their roles in mitochondrial energy production, methylation, and neurotransmission.
- Apply functional testing strategies, including neurotransmitter analysis and DNA methylation profiling, to guide personalized interventions for patients experiencing mood symptoms associated with iatrogenic nutrient depletion.
Saliva, Urine, or Blood? Choosing the Right Hormone Test for Your Patients
Presented by Dr. Brandon Lundell, DC, APC, DABCI, IFMCP, Dip. Ac., NE, CAC | May 13, 2026 at 12 PM Pacific
Hormone imbalance is one of the most common presentations in functional medicine-but the wrong testing methodology can be more dangerous than no testing at all. When patients on transdermal or pellet hormone therapy show "normal" blood levels while their symptoms worsen, the problem isn't the patient-it's the test. Fat-soluble hormones applied to the skin bypass the liver, accumulate in adipose tissue, and bind to red blood cell membranes rather than circulating in plasma, making serum testing fundamentally unreliable for monitoring parenteral hormone therapy. In this one-hour webinar, Dr. Lundell walks practitioners through the complete Doctor's Data hormone testing menu-including the Comprehensive Saliva Hormone Panel with melatonin, the HUMAP urinary metabolite profile, and the Basic Hormone Profile for cost-effective follow-up-equipping you to select the right test for every clinical scenario. You'll learn why morning cortisol is the single most important marker for HPA axis assessment, evidence-based strategies for elevated nighttime cortisol, and the emerging science of the gut-gonadal axis and its profound implications for fertility, menopause, and andropause. The presentation culminates with a case study of a menopausal woman made worse by hormone overtreatment and a critical examination of the popular claim that testosterone protects women against breast cancer-a myth that doesn't survive scrutiny of the actual data.
Learning Objectives:
- Navigate the Doctor's Data hormone testing menu and select the appropriate panel based on clinical presentation, treatment monitoring needs, and cost considerations
- Explain why morning cortisol is the most clinically significant marker for HPA axis dysregulation and identify evidence-based interventions for elevated nighttime cortisol
- Describe the gut-gonadal axis and its implications for fertility, menopause, andropause, PCOS, and endometriosis in clinical practice
- Differentiate between blood, urine, and saliva hormone testing and articulate why serum testing is unreliable for monitoring parenteral hormone therapy
- Critically evaluate the claim that exogenous testosterone is breast cancer-protective in women and implement superior evidence-based strategies for breast cancer risk reduction
Harnessing the Microbiome to Boost GLP-1: Insights from the GI360™
Presented by Jeannie Gorman, MS, CCN | June 3, 2026 at 12 PM Pacific
This webinar will explore how the GI360™ provides a comprehensive view of the microbiome and dysbiosis, with insights into GLP-1 signaling pathways. Learn practical applications for patients with GI, autoimmune, cardiovascular, neurological, or skin conditions, and discover how stool insights can guide better clinical outcomes.
Learning Objectives:
- Describe the GI360™ complimentary methodologies and applications
- Identify patients who benefit from stool testing
- Interpret markers of dysbiosis and GLP-1-modulating bacteria
- Apply targeted probiotics, soluble fiber, diet, and dysbiosis therapies to support microbiome health and GLP-1 signal pathways
- Explain the role of retesting for optimizing microbiome and GLP-1-related outcomes